Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Journal: Transfusion
Published: January 03, 2020
Clofarabine followed by haploidentical stem cell transplant using fludarabine, busulfan, and total-body irradiation with post-transplant cyclophosphamide in non-remission AML.
Journal: International journal of hematology
Published: December 13, 2017
Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone.
Journal: Cancer biology & therapy
Published: December 02, 2016
Should all patients with SCLC receive prophylactic cranial irradiation if they have responded to treatment? The time has come to improve on a former standard.
Journal: Clinical advances in hematology & oncology : H&O
Published: April 09, 2016
Consolidation With Radiation or Concurrent Chemo-Radiation After Chemotherapy Results in Durable Complete Remissions of Isolated Nodal Recurrences of Urothelial Cancer: A Case Series and Review.
Journal: Clinical genitourinary cancer
Published: October 15, 2015
Optimal Frequency of Psychosocial Distress Screening in Radiation Oncology.
Journal: Journal of oncology practice
Published: July 19, 2015
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
Journal: British journal of haematology
Published: May 06, 2015
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 22, 2015
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402.
Journal: British journal of haematology
Published: January 15, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627).
Journal: Neuro-oncology
Published: October 24, 2014
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 17, 2014
Last Updated: 09/26/2026